(Q44447881)

English

Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

allergic rhinitis

1 reference

based on heuristic

inferred from title

seasonal allergic rhinitis

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

F Horak

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Stübner

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Zieglmeyer

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 June 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

58

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

481-485

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12757447%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Allergy and allergic diseases. First of two parts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Mode of action of intranasal corticosteroids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Desloratadine in the treatment of chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Molecular and cellular mechanisms of allergic disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Desloratadine: A new, nonsedating, oral antihistamine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Effects of intravenous infusions of prostaglandin D2 in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

21 January 2018

Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of IL-4 on human nasal mucosal responses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ideal pharmacotherapy for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment strategies designed to minimize medical complications of allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00148.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44447881&oldid=2146180450"